5-[4-[2-[5-(6-amino-3-pyridinyl)-1,2,4-oxadiazol-3-yl]-3-methylbutan-2-yl]phenyl]pyrimidin-2-amine;3-[2-[4-(5-methoxy-3-pyridinyl)phenyl]-3-methylbutan-2-yl]-5-pyrazin-2-yl-1,2,4-oxadiazole;5-[4-[3-methyl-2-[5-(1-methylpiperidin-4-yl)-1,2,4-oxadiazol-3-yl]butan-2-yl]phenyl]pyrimidin-2-amine;5-[4-[3-methyl-2-(5-phenyl-1,2,4-oxadiazol-3-yl)butan-2-yl]phenyl]pyrimidin-2-amine

C91H99N23O5 — CID 160517835

IUPAC5-[4-[2-[5-(6-amino-3-pyridinyl)-1,2,4-oxadiazol-3-yl]-3-methylbutan-2-yl]phenyl]pyrimidin-2-amine;3-[2-[4-(5-methoxy-3-pyridinyl)phenyl]-3-methylbutan-2-yl]-5-pyrazin-2-yl-1,2,4-oxadiazole;5-[4-[3-methyl-2-[5-(1-methylpiperidin-4-yl)-1,2,4-oxadiazol-3-yl]butan-2-yl]phenyl]pyrimidin-2-amine;5-[4-[3-methyl-2-(5-phenyl-1,2,4-oxadiazol-3-yl)butan-2-yl]phenyl]pyrimidin-2-amine
SMILESCC(C)C(C)(c1ccc(-c2cnc(N)nc2)cc1)c1noc(-c2ccc(N)nc2)n1.CC(C)C(C)(c1ccc(-c2cnc(N)nc2)cc1)c1noc(-c2ccccc2)n1.CC(C)C(C)(c1ccc(-c2cnc(N)nc2)cc1)c1noc(C2CCN(C)CC2)n1.COc1cncc(-c2ccc(C(C)(c3noc(-c4cnccn4)n3)C(C)C)cc2)c1
InChIInChI=1S/C23H30N6O.C23H23N5O2.C23H23N5O.C22H23N7O/c1-15(2)23(3,21-27-20(30-28-21)17-9-11-29(4)12-10-17)19-7-5-16(6-8-19)18-13-25-22(24)26-14-18;1-15(2)23(3,22-27-21(30-28-22)20-14-24-9-10-26-20)18-7-5-16(6-8-18)17-11-19(29-4)13-25-12-17;1-15(2)23(3,21-27-20(29-28-21)17-7-5-4-6-8-17)19-11-9-16(10-12-19)18-13-25-22(24)26-14-18;1-13(2)22(3,20-28-19(30-29-20)15-6-9-18(23)25-10-15)17-7-4-14(5-8-17)16-11-26-21(24)27-12-16/h5-8,13-15,17H,9-12H2,1-4H3,(H2,24,25,26);5-15H,1-4H3;4-15H,1-3H3,(H2,24,25,26);4-13H,1-3H3,(H2,23,25)(H2,24,26,27)
InChIKeyQTWSAVSJIKEOQG-UHFFFAOYSA-N
MW1594.95 g/mol
LogP16.89
Rot. Bonds21

About 5-[4-[2-[5-(6-amino-3-pyridinyl)-1,2,4-oxadiazol-3-yl]-3-methylbutan-2-yl]phenyl]pyrimidin-2-amine;3-[2-[4-(5-methoxy-3-pyridinyl)phenyl]-3-methylbutan-2-yl]-5-pyrazin-2-yl-1,2,4-oxadiazole;5-[4-[3-methyl-2-[5-(1-methylpiperidin-4-yl)-1,2,4-oxadiazol-3-yl]butan-2-yl]phenyl]pyrimidin-2-amine;5-[4-[3-methyl-2-(5-phenyl-1,2,4-oxadiazol-3-yl)butan-2-yl]phenyl]pyrimidin-2-amine

5-[4-[2-[5-(6-amino-3-pyridinyl)-1,2,4-oxadiazol-3-yl]-3-methylbutan-2-yl]phenyl]pyrimidin-2-amine;3-[2-[4-(5-methoxy-3-pyridinyl)phenyl]-3-methylbutan-2-yl]-5-pyrazin-2-yl-1,2,4-oxadiazole;5-[4-[3-methyl-2-[5-(1-methylpiperidin-4-yl)-1,2,4-oxadiazol-3-yl]butan-2-yl]phenyl]pyrimidin-2-amine;5-[4-[3-methyl-2-(5-phenyl-1,2,4-oxadiazol-3-yl)butan-2-yl]phenyl]pyrimidin-2-amine (PubChem CID 160517835) has the molecular formula C91H99N23O5 and a molecular weight of 1594.95 g/mol. Its IUPAC name is 5-[4-[2-[5-(6-amino-3-pyridinyl)-1,2,4-oxadiazol-3-yl]-3-methylbutan-2-yl]phenyl]pyrimidin-2-amine;3-[2-[4-(5-methoxy-3-pyridinyl)phenyl]-3-methylbutan-2-yl]-5-pyrazin-2-yl-1,2,4-oxadiazole;5-[4-[3-methyl-2-[5-(1-methylpiperidin-4-yl)-1,2,4-oxadiazol-3-yl]butan-2-yl]phenyl]pyrimidin-2-amine;5-[4-[3-methyl-2-(5-phenyl-1,2,4-oxadiazol-3-yl)butan-2-yl]phenyl]pyrimidin-2-amine.

Molecular Properties

Compound Name5-[4-[2-[5-(6-amino-3-pyridinyl)-1,2,4-oxadiazol-3-yl]-3-methylbutan-2-yl]phenyl]pyrimidin-2-amine;3-[2-[4-(5-methoxy-3-pyridinyl)phenyl]-3-methylbutan-2-yl]-5-pyrazin-2-yl-1,2,4-oxadiazole;5-[4-[3-methyl-2-[5-(1-methylpiperidin-4-yl)-1,2,4-oxadiazol-3-yl]butan-2-yl]phenyl]pyrimidin-2-amine;5-[4-[3-methyl-2-(5-phenyl-1,2,4-oxadiazol-3-yl)butan-2-yl]phenyl]pyrimidin-2-amine
PubChem CID160517835
Molecular FormulaC91H99N23O5
Molecular Weight1594.95 g/mol
Exact Mass1593.82
IUPAC Name5-[4-[2-[5-(6-amino-3-pyridinyl)-1,2,4-oxadiazol-3-yl]-3-methylbutan-2-yl]phenyl]pyrimidin-2-amine;3-[2-[4-(5-methoxy-3-pyridinyl)phenyl]-3-methylbutan-2-yl]-5-pyrazin-2-yl-1,2,4-oxadiazole;5-[4-[3-methyl-2-[5-(1-methylpiperidin-4-yl)-1,2,4-oxadiazol-3-yl]butan-2-yl]phenyl]pyrimidin-2-amine;5-[4-[3-methyl-2-(5-phenyl-1,2,4-oxadiazol-3-yl)butan-2-yl]phenyl]pyrimidin-2-amine
SMILESCC(C)C(C)(c1ccc(-c2cnc(N)nc2)cc1)c1noc(-c2ccc(N)nc2)n1.CC(C)C(C)(c1ccc(-c2cnc(N)nc2)cc1)c1noc(-c2ccccc2)n1.CC(C)C(C)(c1ccc(-c2cnc(N)nc2)cc1)c1noc(C2CCN(C)CC2)n1.COc1cncc(-c2ccc(C(C)(c3noc(-c4cnccn4)n3)C(C)C)cc2)c1
InChIInChI=1S/C23H30N6O.C23H23N5O2.C23H23N5O.C22H23N7O/c1-15(2)23(3,21-27-20(30-28-21)17-9-11-29(4)12-10-17)19-7-5-16(6-8-19)18-13-25-22(24)26-14-18;1-15(2)23(3,22-27-21(30-28-22)20-14-24-9-10-26-20)18-7-5-16(6-8-18)17-11-19(29-4)13-25-12-17;1-15(2)23(3,21-27-20(29-28-21)17-7-5-4-6-8-17)19-11-9-16(10-12-19)18-13-25-22(24)26-14-18;1-13(2)22(3,20-28-19(30-29-20)15-6-9-18(23)25-10-15)17-7-4-14(5-8-17)16-11-26-21(24)27-12-16/h5-8,13-15,17H,9-12H2,1-4H3,(H2,24,25,26);5-15H,1-4H3;4-15H,1-3H3,(H2,24,25,26);4-13H,1-3H3,(H2,23,25)(H2,24,26,27)
InChIKeyQTWSAVSJIKEOQG-UHFFFAOYSA-N
XLogP16.89
TPSA401.13 Ų
H-Bond Donors4
H-Bond Acceptors28
Rotatable Bonds21
Heavy Atoms119
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001594.95
LogP ≤ 516.89
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1028

Analyze 5-[4-[2-[5-(6-amino-3-pyridinyl)-1,2,4-oxadiazol-3-yl]-3-methylbutan-2-yl]phenyl]pyrimidin-2-amine;3-[2-[4-(5-methoxy-3-pyridinyl)phenyl]-3-methylbutan-2-yl]-5-pyrazin-2-yl-1,2,4-oxadiazole;5-[4-[3-methyl-2-[5-(1-methylpiperidin-4-yl)-1,2,4-oxadiazol-3-yl]butan-2-yl]phenyl]pyrimidin-2-amine;5-[4-[3-methyl-2-(5-phenyl-1,2,4-oxadiazol-3-yl)butan-2-yl]phenyl]pyrimidin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 5-[4-[2-[5-(6-amino-3-pyridinyl)-1,2,4-oxadiazol-3-yl]-3-methylbutan-2-yl]phenyl]pyrimidin-2-amine;3-[2-[4-(5-methoxy-3-pyridinyl)phenyl]-3-methylbutan-2-yl]-5-pyrazin-2-yl-1,2,4-oxadiazole;5-[4-[3-methyl-2-[5-(1-methylpiperidin-4-yl)-1,2,4-oxadiazol-3-yl]butan-2-yl]phenyl]pyrimidin-2-amine;5-[4-[3-methyl-2-(5-phenyl-1,2,4-oxadiazol-3-yl)butan-2-yl]phenyl]pyrimidin-2-amine?
The IUPAC name of 5-[4-[2-[5-(6-amino-3-pyridinyl)-1,2,4-oxadiazol-3-yl]-3-methylbutan-2-yl]phenyl]pyrimidin-2-amine;3-[2-[4-(5-methoxy-3-pyridinyl)phenyl]-3-methylbutan-2-yl]-5-pyrazin-2-yl-1,2,4-oxadiazole;5-[4-[3-methyl-2-[5-(1-methylpiperidin-4-yl)-1,2,4-oxadiazol-3-yl]butan-2-yl]phenyl]pyrimidin-2-amine;5-[4-[3-methyl-2-(5-phenyl-1,2,4-oxadiazol-3-yl)butan-2-yl]phenyl]pyrimidin-2-amine (CID 160517835) is 5-[4-[2-[5-(6-amino-3-pyridinyl)-1,2,4-oxadiazol-3-yl]-3-methylbutan-2-yl]phenyl]pyrimidin-2-amine;3-[2-[4-(5-methoxy-3-pyridinyl)phenyl]-3-methylbutan-2-yl]-5-pyrazin-2-yl-1,2,4-oxadiazole;5-[4-[3-methyl-2-[5-(1-methylpiperidin-4-yl)-1,2,4-oxadiazol-3-yl]butan-2-yl]phenyl]pyrimidin-2-amine;5-[4-[3-methyl-2-(5-phenyl-1,2,4-oxadiazol-3-yl)butan-2-yl]phenyl]pyrimidin-2-amine.
What is the SMILES notation for 5-[4-[2-[5-(6-amino-3-pyridinyl)-1,2,4-oxadiazol-3-yl]-3-methylbutan-2-yl]phenyl]pyrimidin-2-amine;3-[2-[4-(5-methoxy-3-pyridinyl)phenyl]-3-methylbutan-2-yl]-5-pyrazin-2-yl-1,2,4-oxadiazole;5-[4-[3-methyl-2-[5-(1-methylpiperidin-4-yl)-1,2,4-oxadiazol-3-yl]butan-2-yl]phenyl]pyrimidin-2-amine;5-[4-[3-methyl-2-(5-phenyl-1,2,4-oxadiazol-3-yl)butan-2-yl]phenyl]pyrimidin-2-amine?
The canonical SMILES for 5-[4-[2-[5-(6-amino-3-pyridinyl)-1,2,4-oxadiazol-3-yl]-3-methylbutan-2-yl]phenyl]pyrimidin-2-amine;3-[2-[4-(5-methoxy-3-pyridinyl)phenyl]-3-methylbutan-2-yl]-5-pyrazin-2-yl-1,2,4-oxadiazole;5-[4-[3-methyl-2-[5-(1-methylpiperidin-4-yl)-1,2,4-oxadiazol-3-yl]butan-2-yl]phenyl]pyrimidin-2-amine;5-[4-[3-methyl-2-(5-phenyl-1,2,4-oxadiazol-3-yl)butan-2-yl]phenyl]pyrimidin-2-amine is CC(C)C(C)(c1ccc(-c2cnc(N)nc2)cc1)c1noc(-c2ccc(N)nc2)n1.CC(C)C(C)(c1ccc(-c2cnc(N)nc2)cc1)c1noc(-c2ccccc2)n1.CC(C)C(C)(c1ccc(-c2cnc(N)nc2)cc1)c1noc(C2CCN(C)CC2)n1.COc1cncc(-c2ccc(C(C)(c3noc(-c4cnccn4)n3)C(C)C)cc2)c1.
What is the InChIKey of 5-[4-[2-[5-(6-amino-3-pyridinyl)-1,2,4-oxadiazol-3-yl]-3-methylbutan-2-yl]phenyl]pyrimidin-2-amine;3-[2-[4-(5-methoxy-3-pyridinyl)phenyl]-3-methylbutan-2-yl]-5-pyrazin-2-yl-1,2,4-oxadiazole;5-[4-[3-methyl-2-[5-(1-methylpiperidin-4-yl)-1,2,4-oxadiazol-3-yl]butan-2-yl]phenyl]pyrimidin-2-amine;5-[4-[3-methyl-2-(5-phenyl-1,2,4-oxadiazol-3-yl)butan-2-yl]phenyl]pyrimidin-2-amine?
The InChIKey is QTWSAVSJIKEOQG-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H30N6O.C23H23N5O2.C23H23N5O.C22H23N7O/c1-15(2)23(3,21-27-20(30-28-21)17-9-11-29(4)12-10-17)19-7-5-16(6-8-19)18-13-25-22(24)26-14-18;1-15(2)23(3,22-27-21(30-28-22)20-14-24-9-10-26-20)18-7-5-16(6-8-18)17-11-19(29-4)13-25-12-17;1-15(2)23(3,21-27-20(29-28-21)17-7-5-4-6-8-17)19-11-9-16(10-12-19)18-13-25-22(24)26-14-18;1-13(2)22(3,20-28-19(30-29-20)15-6-9-18(23)25-10-15)17-7-4-14(5-8-17)16-11-26-21(24)27-12-16/h5-8,13-15,17H,9-12H2,1-4H3,(H2,24,25,26);5-15H,1-4H3;4-15H,1-3H3,(H2,24,25,26);4-13H,1-3H3,(H2,23,25)(H2,24,26,27).
What are the key properties of 5-[4-[2-[5-(6-amino-3-pyridinyl)-1,2,4-oxadiazol-3-yl]-3-methylbutan-2-yl]phenyl]pyrimidin-2-amine;3-[2-[4-(5-methoxy-3-pyridinyl)phenyl]-3-methylbutan-2-yl]-5-pyrazin-2-yl-1,2,4-oxadiazole;5-[4-[3-methyl-2-[5-(1-methylpiperidin-4-yl)-1,2,4-oxadiazol-3-yl]butan-2-yl]phenyl]pyrimidin-2-amine;5-[4-[3-methyl-2-(5-phenyl-1,2,4-oxadiazol-3-yl)butan-2-yl]phenyl]pyrimidin-2-amine?
5-[4-[2-[5-(6-amino-3-pyridinyl)-1,2,4-oxadiazol-3-yl]-3-methylbutan-2-yl]phenyl]pyrimidin-2-amine;3-[2-[4-(5-methoxy-3-pyridinyl)phenyl]-3-methylbutan-2-yl]-5-pyrazin-2-yl-1,2,4-oxadiazole;5-[4-[3-methyl-2-[5-(1-methylpiperidin-4-yl)-1,2,4-oxadiazol-3-yl]butan-2-yl]phenyl]pyrimidin-2-amine;5-[4-[3-methyl-2-(5-phenyl-1,2,4-oxadiazol-3-yl)butan-2-yl]phenyl]pyrimidin-2-amine has a molecular weight of 1594.95 g/mol, XLogP of 16.89, 21 rotatable bonds, 4 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[4-[2-[5-(6-amino-3-pyridinyl)-1,2,4-oxadiazol-3-yl]-3-methylbutan-2-yl]phenyl]pyrimidin-2-amine;3-[2-[4-(5-methoxy-3-pyridinyl)phenyl]-3-methylbutan-2-yl]-5-pyrazin-2-yl-1,2,4-oxadiazole;5-[4-[3-methyl-2-[5-(1-methylpiperidin-4-yl)-1,2,4-oxadiazol-3-yl]butan-2-yl]phenyl]pyrimidin-2-amine;5-[4-[3-methyl-2-(5-phenyl-1,2,4-oxadiazol-3-yl)butan-2-yl]phenyl]pyrimidin-2-amine is sourced from PubChem (CID 160517835), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).